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STUDY OF THE DEVELOPMENTAL PATTERN OF HEME
CATABOLISM IN LIVER AND THE EFFECTS
OF COBALT ON CYTOCHROME P-450 AND THE RATE OF
HEME OXIDATION DURING THE NEONATAL PERIOD*
By MAHIN D . MAINES AND ATTALLAH KAPPAS
(From The Rockefeller University, New York 10021)
The present experiments were undertaken to study heme oxidation in neonatal
liver cells with particular reference to the comparative development of this
enzymic activity and of cytochrome P-450 mediated drug oxidation ; and to
examine the responses of both P-450 and microsomal heme oxidation activity to
the trace metal cobalt .
Catabolism ofheme to biliverdin involves the oxidative cleavage of the ring tetrapyrrole
of heme by a microsomal enzyme system, to form the linear tetrapyrrole of the green
pigment, biliverdin . The latter is subsequently reduced by a cytosol enzyme to form
bilirubin, which then undergoes conjugation and excretion . It has recently been proposed
(1) that in the microsomal oxidation of heme-a process known to require NADPH and
molecular oxygen-cytochrome P-450 plays an essential role (2), comparable to that which
this heme-protein plays in the mixed function oxidation of drugs and other foreign chemi-
cals (3) . However, apart from their mutual requirements for NADPH and molecular O, ,
drug and heme oxidations differ significantly in a number of characteristics (1, 4) and
these differences have raised doubts about the involvement in the latter process of cyto-
chrome P-450 (5, 6) . In recent studies from this laboratory, the striking ability of the trace
metal, cobalt, to induce microsomal heme oxidation in liver cells was demonstrated, and
in the course of this work, it proved possible to completely dissociate heme oxidation from
cytochrome P-450 and P-450 dependent drug metabolism (7, 8) . Thus, heme catabolism in
liver cells is mediated by a non-P-450 dependent enzymic system distinct from that
involved in drug transformation .
The dissociation of oxidative processes for heme and for drugs has been further
investigated, in this report, in terms of the comparative developmental patterns of both
activities during the postnatal period and the responses of P-450 and heme oxidation
activity to cobalt . There are some data available concerning the pattern of development of
hepatic drug metabolizing enzymes in neonates (9, 10), and information concerning the
comparative development ofheme catabolizing activity of liver cells and ofthe response of
this enzymic activity to cobalt would be of considerable interest, in view of the inhibitory
effect of the metal on heme synthesis (11) and the marked restriction on chemical
induction of S-aminolevulinate synthetase (ALAS),' the rate limiting enzyme of heme
synthesis, which characterizes late gestation and early postnatal life (10, 12) .
* This research was supported in part by U.S . Public Health Service grant ES-01055 ; an institu-
tional grant from The Rockefeller Foundation for studies in reproductive physiology ; and by grants
from the Exxon and Mobil Corporations .
' Abbreviation used in thispaper: ALAS, ö-aminolevulinate synthetase .
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mental patterns of hepatic cell capacity to effect heme and drug oxidations in the
postnatal period, thus emphasizing the distinctiveness of these microsomal
enzyme activities and their regulatory factors . The response of the heme
oxidation system in neonatal liver to induction by cobalt is also shown to be
substantially different from that of the adult liver . Finally, data are provided on
the rate of heme oxidation in neonates which supports the idea that postnatal
jaundice results not only from immaturity of bilirubin conjugation mechanisms,
but from hepatic overproduction of the pigment as well .
Materials .
￿
Pregnant Sprague-Dawley rats were purchased from Holtzman Co ., Madison, Wis . at
the 7th day of gestation . All chemicals were purchased from Sigma Chemical Co., St . Louis, Mo .
Heme solutions (hematin, iron protoporphyrin-IX) were prepared as described earlier (6) . Cobalt-
(ous) chloride was injected subcutaneously at 25,umol/100 gbody wt 24 h before sacrifice . In the case
of embryos (-8 days) and fetuses (0 days, or 21 days gestation), only the mothers were injected with
the metal .
Tissue Preparation . It was not possible to isolate sufficient amounts of hepatic microsomal
fractions from embryos on the 13th day of gestation (-8 day, Fig . 1) so that at this stage of
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FIG. 1 .
￿
Developmental pattern of hepatic heme oxidation in the rat and the effect of cobalt
on this enzyme activity . Postnatal rats were injected subcutaneously with cobalt chloride (60
mg/kg) or saline (control), and the liver microsomal fractions were prepared 24 h after
treatment by pooling livers from 4-8 rats . Heme oxidation activity was measured as described
previously (8) . The effect ofcobalt on the prenatal rats was investigated by injecting pregnant
females with cobalt as described above . The oxidative activity is expressed as thenanomoles of
bilirubin formed per milligram of protein perhour . Each point represents the mean value of
three experiments .
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development "microsomal fractions" from whole embryos were prepared . However, in all other
instances microsomal fractions from individual organs were used for the assays . Animals were
decapitated, livers and spleens were removed, pooled and homogenized in potassium phosphate
buffer 0.1 M, pH 7.4 and centrifuged at 9,000gfor 20 min . Thereafter, the microsomal fractionswere
prepared as described earlier (6, 13) . The hepatic microsomal pellets were resuspended in buffer to a
concentration of 9 mg/ml whichwasused in the heme oxygenaseassay ; and were further diluted to 4.5
mg/ml for the ethylmorphine N-demethylation assay . Splenic microsomal pellets were resuspended
in buffer to a protein concentration of 4.5 mg/ml which was used in the heme oxidation assays . The
105,000 g supernatant fraction from adult rat livers was used as the source of the cytosol enzyme,
biliverdin reductase (14) . In this case the livers were perfused with 0.9% NaCI in situ and the
microsomal fractions were prepared as before .The protein concentration of this fraction wasadjusted
to 10 mg/ml .
Spectral Studies . The hepatic microsomal content of cytochrome P-450 was measured as
described by Omura and Sato (15) from the reduced minus CO-difference spectrum using sodium
dithionite as thereducing agent .NADPH-cytochrome c reductase activity wasmeasured as described
by Williams and Kamin (16) . The microsomal content of heme was determined by the pyridine
hemochromogen method of Paul et al . (17) . All spectral studies were carried out using an Aminco
Chance DW-2 spectrophotometer (American Instrument Co ., Inc ., Silver Springs, Md .) .
Protein was determined using the method of Lowry et al . (18) . All experiments were conducted at
least three times and the results are expressed as the average of these experiments fSD. The data
were analyzed using the Student's t test and the value of P < 0.05 was considered as denoting
significance .
Enzyme Assays .
￿
Hepatic and splenic heme oxidation activities were measured as described in
detail previously (8) by incubating (37°C, 15 min) heme at a final concentration of 17 JAM in a 3 ml
incubation mixture containing 6-9 mg of hepatic microsomal protein or 4.5 mg splenic microsomal
protein, 5 mg liver 105,000 gsupernatant fraction (biliverdin reductase), MgCl, (2 mM), anNADPH
generating system consisting of glucose-6-phosphate (0.85 mM), glucose-6-phosphate dehydrogenase
(1 .5 U), NADP (0 .8 mM), and phosphate buffer, 0.09 M. The amount of bilirubin formed was
measured usingan extinction coefficient of 40mM -'cm-`between 464-530 nm .
The activity of the hepatic mixed function oxidase system was monitored by measuring
N-demethylation of the prototype drug, ethylmorphine, as described earlier (19) ; formaldehyde
formed was determined by the method of Nash (20) .
Results
The developmental pattern of heme oxidation, and the inducing effects of
cobalt on this process, in embryos (-8 days) ; in fetuses at term (0 days), and at
various times in postnatal life are depicted in Fig. 1 . As noted, the data for
embryos (-8 days) reflect whole body heme oxidation activity ; all other data
reflect this enzyme activity in liver alone. At the time periods (-8 days) and (0
days) heme oxidation activity following cobalt, represents enzyme activity in
embryos or fetuses after the metal was administered to the maternal host . At all
other points, the metal was administered directly to the neonate.
Heme oxidation in fetal liver (0 days) was maintained at a level approximately
equivalent to that found in normal adult livers (8) and the same level ofenzyme
activity was found in the tissue preparations from whole embryos (-8 days) .
However, in the latter, there was a large contribution ofwhole embryo protein to
the calculated levels of enzyme activity ; this would thus be consistent with the
findings (21) that at this stage of development the rate of heme oxidation in
embryonic liver may be somewhat greater than in adult liver. In the immediate
postnatal period, heme oxidation activity in liver increased rapidly, reaching
levels between 4-7 days, which were 3-5 times higher than those in adults . This
increase in the rate of hepatic heme catabolism returned towards normal within
about 2 wk .MAHIN D. MAINES AND ATTALLAH KAPPAS
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The effect of cobalt on this process was of interest . In the adult liver, cobalt
exerts potent inducing action on heme oxidation increasing the level of this
enzymatic activity between 7-10 times normal (7, 8) ; in the neonate this inducing
activity of the metal was substantially less . When cobalt was administered to the
maternal host at 21 days gestation the metal exerted no inducing action on heme
oxidation in the fetus at all (0 days, Fig . 1) ; within the first postnatal week, metal
inducibility of the enzyme commenced and reached levels 150-200% higher than
control activity, while at 4-5 wk of age cobalt induced hepatic heme oxidation to
the same extent (7-10 times control levels) as it did in adult animals .
The reason for the rapid and substantial increase in the rate of hepatic heme
oxidation during the first week of postnatal life is not known with certainty. This
enhanced enzyme activity could result from postpartum breakdown of erythroid
elements in the liver and/or in the peripheral circulation with release of free
hemoglobin which itself is known to be an inducer of hepatic heme oxygenase
activity (22) . However, while it is known that in the neonatal rat most of the
circulating erythroid cells are reticulocytes, the specific kinetics of red cell
turnover at this time of life have not been studied in detail ; thus it remains
unclear whether the high levels of hepatic heme oxidation found in neonatal
livers do in fact reflect the inducing action of free hemoglobin derived from lysed
erythrocytes or their precursors . Induction of hepatic heme oxidation in this
period could also reflect (a) the action of circulating humoral agents which are
known to alterheme metabolism (23) ; (b) the release of this enzyme system from
repressed synthesis ofenzyme components during gestation as occurs with ALAS
(12) ; (c) nutritional changes associated with parturition (21) or combined effects
of these or other (24) regulating processes on the system .
Fig . 2 depicts the comparative developmental patterns of the two major
oxidative enzyme complexes localized in hepatic microsomes ; the system for
heme and the system for drugs such as the prototype substrate, ethylmorphine .
As this figure makes clear, these enzyme systems exhibited dissimilar patterns of
development, with the rate ofdrug metabolism being verylowduring the first 2-3
wk of postnatal life while the rate of heme oxidation at this time increased
rapidly to levels which were substantially higher than those characteristic of the
adult . Conversely, drug metabolism began to increase rapidlyto adult levels after
the 3rd week of life while heme oxidation activity diminished sharply during this
period . It is of interest that the pattern of cytochrome P-450 development was
also reciprocal to that of heme oxidation activity, with hepatic content of this
heme-protein being low when the rate of heme catabolism is high in liver cells ;
and increasing (as does the rate of mixed function oxidation of drugs) in late
postnatal life when the rate of heme catabolism diminishes . The distinctiveness
of the microsomal oxidative systems for heme and for drugs is also reflected in
the observation that the rate of heme catabolism in embryonic-fetal life is quite
high, whereas in contrast drug oxidizing activity at this time is low.
The effects of cobalt on hepatic cytochrome P-450 and on total content of
microsomal heme during postnatal development are depicted in Fig . 3. As shown,
hepaticcontent ofcytochrome P-450 increasedafter birth, somewhat more rapidly
during the first postnatal week, and more gradually thereafter, until adult con-
tents of the heme-protein in liver cells were reached . Cobalt exerted differential
effects on the heme-protein during earlyandlate postnatal stages of development .1404
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FIG. 2 .
￿
The comparative developmental patterns of the hepatic microsomal enzyme systems
which oxidizedrugs and which oxidize heme . Hepatic microsomal fractionswere prepared by
pooling livers from 4-S rats . The developmental pattern of the drug metabolizing system was
studied by measuring oxidative N-demethylation activity using ethylmorphine as the
prototype substrate and the results are expressed as the nanomoles of product (p-amino-
phenol) formed per milligram of protein per hour . The developmental pattern of the heme
oxidation was assayed using hematin as thesubstrate and theenzyme activity is expressed as
nanomolesof bilirubin formed per milligram of protein perhour . The procedures described in
the Materials and Methods section were used for the analysis of these activities . Each point
represents the mean value of three experiments .
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FIG. 3 .
￿
The effects of cobalt treatment on the microsomal contents of heme and cytochrome
P-450 in the livers of developing neonates . Hepatic microsomal fractions were prepared from
cobalt chloride (60 mg/kg) or saline treated postnatal rats and cytochrome P-450 was
determined by the method ofOmura and Sato (15) ; total microsomal heme was measured by
the method of Paul el al . (17) .MAHIN D. MAINES AND ATTALLAH KAPPAS
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During the first 7-14 days of neonatal life cytochrome P-450 appeared somewhat
refractory to the metal, although cobalt is known to substantially diminish hepatic
concentrations of the heme-protein in adult liver (7, 8, 25) . There is clear evidence
that there is more than one species of the heme-protein collectively termed
"P-450" and it is possible therefore that there is in the neonate a specific P-450
moiety having special resistance towards degradation by the activated heme
oxidation system . The degradative effects exerted by cobalt on P-450 increased
as maturation proceeded ; and the total microsomal content of heme exhibited
responses to the metal in earlyandlate neonatal life similar to those ofcytochrome
P-450 (Fig . 3) .
Table I depicts the effects of cobalt on hepatic heme oxidation and other
microsomal enzyme activity in 4-day old control neonates ; in 4-day old neonates
TABLE I
Microsomal Enzyme Activities in Neonatal Animals after Direct Cobalt Injection or
Injection of the Metal into the Nursing Mother
The nursing mothers (group 1) or the suckling neonates (group 2) were treatedwith cobalt (60 mg/kg,
subcutaneously) . The hepatic microsomal fractions from the neonates were prepared from pooled
livers (4-5) and various microsomal enzyme activities andcomponents were measured as described in
the Materials andMethods. Allexperiments were carried outthreetimesandmean values are shown.
Values in group 2 animals marked by an asterisk are significantly different (P< 0.05) from those of
the group 1 and 3 animals.
exposed to the metal via maternal milk ; and in 4-day old neonates receiving the
metal by direct injection . In control neonates hepatic heme oxygenase activity
was elevated above normal adult levels as expected ; the ethylmorphine demeth-
ylation rate was low as was NADPH cytochrome c reductase activity and
microsomal contents of P-450 and total heme . Direct injection of the neonate
with cobalt produced a small increase in the rate ofheme oxidation ; a reciprocal
change in drug metabolism ; and decreases in P-450 and microsomal heme
content as earlier observed in adults (7, 8) . The change in NADPH-cytochrome c
reductase activity was not statistically significant . In contrast, 4-day old
neonates, suckling from mothers who had received comparable doses of cobalt,
but who had not themselves been injected with the metal, displayed no signifi-
cant alterations in the parameters measured, the data for the enzyme activities
determined for the group 3 neonates not being significantly different from those
forthe group 1 neonates . These findings indicate that in nursingmothers cobalt is
Group Treatment
Bilirubin
formed
Ethylmorphine Cytochrome Microsomal
N-demethylase P-450 heme
TPNH -
cytochrome
c reductase
nmol/mg/h nmol/mg/h nmol/mg nmol/m;g nmol/mg/min
1 4-day old neonate; 4.48 83 .5 0.354 0.614 69.4
mothers injected
with cobalt
2 4-day old neonates ; 7.10* 42.5* 0.265* 0.519* 39.0
cobalt injected
3 4-dayoldneonates ; 4.31 59.2 0.386 0.673 54 .1
controls1406
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not transported to the suckling neonate and supports the idea (8) that the active
(i.e . heme oxygenase inducing) species of cobalt is in the ionic form rather than
the metal in a complexed form as would be the case if cobalt were secreted into
maternal milk .
Heme oxidation in the microsomal fraction from the spleen of neonates
immediately after birth was somewhat lower than that found in adults but
reached the adult range within the first 2 wk of postnatal life . Cobalt had no
inducing effect on this enzyme activity in the spleen in neonates or in adults .
Heme oxidation activity in the livers of pregnant animals at days 13 and 21 of
gestation was not significantly different from this enzyme activity in the livers of
nonpregnant animals. Cobalt induced heme oxidation activity in the livers of
pregnant animals to approximately the same extent (7-10 times) as it did in
controls ; and comparable changes after cobalt treatment occurred in both groups
with respect to the other enzymic parameters measured as well . Gonadectomy
and adrenalectomy in nonpregnant animals and steroid hormone replacements,
had no significant effects on heme oxidation activity of liver microsomes .
NADPH-cytochrome c reductase activity increased gradually during the first 4
wk of postnatal life to adult levels . Moreover, the activity of this enzyme was not
significantly altered at any time by cobalt treatment . The co-factor requirements
of the heme oxidation system in the maternal host during gestation and in
neonates were similar to those of control animals.
Discussion
The present study demonstrates that the developmental patterns of the
microsomal oxidative systems for heme and for drug substrates in liver are
significantly different . Microsomal heme oxidation proceeds at near-adult rates
in late fetal life and undergoes, in the immediate postnatal period, an abrupt and
substantial increase in activity before subsiding, after 14-21 days, to the levels of
enzymic activity characterizing adult animals . In contrast, drug oxidation in
hepatic microsomes, exemplified by the prototype substrate ethylmorphine, pro-
ceeds at a very low rate in late fetal and earlyneonatal life and only reaches adult
levels of activity 4-5 wk after birth . Thus, at the time when drug oxidation in
microsomes has reached its maximum level of activity, the rate of heme
oxidation in liver has diminished to the low levels characteristic of mature
animals . Microsomal contents of total heme and of cytochrome P-450 parallel
more closely the developmental pattern of the drug oxidation, than the heme
oxidation system in liver .
The reasons for the low levels of hepatic cytochrome P-450 in neonates are not
known, although it is suggested that the refractoriness of hepatic ALAS to
chemical induction during this period may account in part for this phenomenon .
In the absence of increased ALAS activity, heme synthesis would be limited to
some extent in liver cells and if heme catabolism were to proceed at higher than
normal rates during the neonatal period, the contents of hepatic heme-proteins
would be expected to be lower than those found in adults . The data presented in
Figs . 1 and 3 are keeping with this view since they demonstrate a reciprocal
relationship between the rate of heme oxidation activity and the microsomalMAHIN D . MAINES AND ATTALLAH KAPPAS
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contents of cytochrome P-450 and total heme . As development progresses, these
parameters change in reverse fashion with a shift to a high level of cytochrome
P-450 and heme occurring as the capacity of hepatic microsomes to oxidize heme
diminishes . These reciprocal alterations suggest, despite earlier uncertainty con-
cerning this question, that endogenous microsomal heme derived from the turn-
over of membrane bound heme-proteins does in fact serve as a substrate for
microsomal heme oxygenase in the liver .
It should be noted that although ALAS is completely refractory to chemical
induction in the immediate postnatal period its basal level of activity shortly
after birth is relatively higher than that in adults ; conversely later in develop-
ment (i.e . 2-4 wk after birth) when basal activity of this liver enzyme is low, it
becomes highly responsive to induction . Thus in the immediate postnatal period
the higher than normal basal activity of hepatic ALAS appears to provide
sufficient heme synthesis such that some increase in heme and heme-protein
(cytochrome P-450) content in liver can take place despite the exaggerated rate of
hepatic heme oxidation activity characterizing this period . In later postnatal life
(i .e . 4-5 wk after birth) the newly developed capacity of ALAS to respond to
chemical or "feed-back" induction can also provide enough heme to sustain
P-450 dependent drug oxidation and to replace heme which is degraded normally
or through the action of exogenous substances such as environmental chemicals,
trace metals etc . In very early, as well as in late postnatal life therefore,
spontaneously occurring or inducibly high-levels ofALAS activity can contribute
to the equilibrium-reflected in the cytochrome P-450 content of microsomes-
which is determined by the rate of heme degradation by heme oxidation, the
turnover rates of microsomal heme-proteins and the rate of heme synthesis in
liver cells .
The disparate effects of cobalt on the rates of oxidation of heme and of drug
substances in hepatic microsomes suggested to us earlier (7, 8) that these
reactions are catalyzed by separate microsomal enzymes . Differences in the
characteristics of these enzymes and in their responses to chemical inducing
agents had been noted by other investigators (26) ; and the dissociation of
cytochrome P-450 from heme catabolism in both the liver (7, 8) and in the spleen
systems (27) provided strong evidence that P-450 is not essential forthe oxidation
of heme, as it is for the mixed function oxidation of drugs and other foreign
chemicals . The demonstration in this study that the microsomal enzymes which
catalyze heme degradation and drug oxidation also undergo significantly
different patterns of development in neonatal life supports our earlier conclusion
concerning the distinctiveness of these enzymes and indicates that the compo-
nents of the microsomal electron transport chain which mediate the oxidation of
drugs are not identical to those involved in the catabolism of heme nor are they
subject to the same control mechanisms .
The precise manner in .which the developmental patterns of heme and drug
oxidations are regulated in the neonatal period are not known . The microsomal
enzymes which catalyze these oxidations belong to a larger category of hepatic
enzymes which show increases in theirspecific activities during certain periods of
postnatal life ; these include uridine diphosphate glucuronyl transferase; tyrosine
aminotransferase ; serine dehydratase; acetyl coenzyme A carboxylase ; fumarase ;1408
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and histidase, among others (see ref . 10) . Hormonal factors have been implicated
in the development of certain hepatic enzymes after birth, and the P-450
dependent microsomal mixed function oxidase complex represents one system
whose pattern of development is dependent in part on sex-steroid influences .
The microsomal heme oxidation system differs in this respect from the
enzyme complex mediating drug transformations, and in this study proved
unresponsive to any major influences exerted by exogenously administered
steroid hormones or those to which the maternal host and developing fetus were
exposed during gestation . The sharp increase in heme oxidation activity
characterizing the immediate postnatal period thus does not seem attributable to
the abrupt alterations in the steroid hormonal milieu of the neonate associated
with parturition . Whatever the basis for this large and transient increase in the
rate of hepatic heme oxidation in liver it is evident that this process results in a
substantial over-production of bilirubin during a period when enzymic conjuga-
tion mechanisms for this pigment in hepatic cells have not matured . Studies
utilizing endogenous production of carbon monoxide as an index of heme
catabolism (28) have also provided data indicating a level of bilirubin production
in normal newborns which is substantially higher than that found in adults .
Neonatal jaundice can thus be considered a consequence not only of delayed
development of the glucuronidation system for bilirubin, but of the excessive
production of this pigment by the heme oxidation system in hepatic, and per-
haps other ce11s2 as well .
It is reasonable to suggest therefore that therapeutic approaches to this prob-
lem may include consideration of means for regulating hepatic heme oxidation
activity at a low rate in early neonatal life, in addition to those present attempts
to induce, prematurely by drugs, the bilirubin glucuronidation system in the liver
or to photo-oxidize circulating bilirubin to derivatives which are nontoxic for the
nervoussystem .
Summary
The comparative development patterns of heme oxidation and of cytochrome
P-450 dependent drug oxidation in rat liver were examined . High levels of heme
oxygenase activity were present in whole embryo preparations at day 13 of
gestation . At birth this enzyme activity in liver was approximately equal to that
ofnormal adult liver . In the immediate postnatal period the rate ofhepatic heme
oxidation increased sharply, reaching levels 3-5 times normal during the first
week postpartum . Thereafter, this enzyme activity progressively decreased and
returned to normal adult levels by the 28th postpartum day . The development of
microsomal heme oxidation and of P-450 dependent drug oxidation exhibited
reciprocal patterns, with the latter being at low levels of activity during the
immediate postnatal period and reaching adult activity only 4 or more wk after
birth .
Cobalt injected into pregnant animals or into nursing mothers did not induce
heme oxygenase in the fetus or suckling neonate . However, when treated directly
2 Maines, M. D., S. Sassa, and A. Kappas . 1975 . Heme oxidation activity of cultured human skin
fibroblasts . Manuscript in preparation .MAHIN D. MAINES AND ATTALLAH KAPPAS
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with the metal, 4-day old neonates exhibited a small induction response of this
enzyme; and the inducibility of heme oxygenase increased gradually to fully
adult levels by the end of the 4th postpartum week. Cobalt at all postnatal
developmental stages was capable of diminishing hepatic contents of total
microsomal heme and P-450 ; however this effect of the metal was small in the
immediate period after birth and increased progressively with maturation .
These findings demonstrate that the patterns of development of hepatic
capacity for carrying out the oxidation of heme and the P-450 dependent
oxidation of drugs are different and thus provide further evidence that these
microsomal enzyme systems are distinct from each other and under separate
regulatory mechanisms. The degree of induction response for hepatic heme
oxygenase evoked by the trace metal, cobalt, was also shown to have develop-
mental determinants as did the susceptibility of hepatic cytochrome P-450 to
degradation by this metal. The very high levels of hepatic heme oxygenase
activity which characterize neonates during the first week of life indicate that
over-production of bilirubin contributes significantly to the mechanism of
neonatal jaundice.
We are indebted to Mrs. Ilona Scher for technical assistance and Miss Ann Marie Quatela for
preparation of the manuscript.
Received for publication 5 March 1975.
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